河南东吉高科有限公司
标准物质
| MSK-TCA2-US-1 | TCA CYCLE STANDARD 2 MIX | 1VIAL |
| MSK-TCA-A | TCA Cycle Standards Mix Sets 1 and 2A | - |
| MSK-TCA-A-US | TCA Cycle Standards Mix Sets 1 and 2A (unlabeled) | - |
| MSK-TCA-US | TCA CYCLE STANDARD MIX SET 1 AND 2 | 2X1VIAL |
| NDLM-6141-PK | Neodymium-145 oxide (¹⁴⁵Nd₂) | - |
| NDLM-860-0.5 | AMMONIA | 0.5L |
| NDLM-860-1-BS | AMMONIA | 1L |
| NDLM-860-1-LB | AMMONIA | 1L |
| NE-2099-1 | NEON | 1L |
| NE-2299-PK | Neon (²²Ne, 99.9%) | - |
| NEX-CRP-N | C-REACTIVE PROTEIN (HUMAN) IN SOLUTION | 100UG |
| NEX-CRP-N-D | C-REACTIVE PROTEIN (HUMAN) DENATURED IN SOLUTION | 100UG |
| NEX-MBP1-CDN-PK | Maltose-binding periplasmic protein (MBP) from . (27-396), apo-open (¹³C, 95%; D, 95%; ¹⁵N, 95%) | - |
| NEX-MBP1-CN-5-PK | Maltose-binding periplasmic protein (MBP) from . (27-396), apo-open (¹³C, 5%; ¹⁵N, 95%) | - |
| NEX-MBP1-CN-PK | Maltose-binding periplasmic protein (MBP) from . (27-396), apo-open (¹³C, 95%; ¹⁵N, 95%) | - |
| NEX-MBP1-ILVFY-PK | Maltose-binding protein (MBP) from . (27-396), apo-open (¹³C, 95%; D, 95%; ¹⁵N, 95%; ¹³CH₃-ILVFY) | - |
| NEX-MBP1-ILV-PK | Maltose-binding protein (MBP) from . (27-396), apo-open (¹³C, 95%; D, 95%; ¹⁵N, 95%; ¹³CH₃-ILV) | - |
| NEX-MBP1-N-PK | Maltose-binding periplasmic protein (MBP) from . (27-396), apo-open (¹⁵N, 95%) | - |
| NEX-MBP1-U-PK | Maltose-binding periplasmic protein (MBP) from . (27-396), apo-open (unlabeled) | - |
| NEX-UB1-HIS-ILVFY-PK | His-ubiquitin (human) (¹³C, 95%; D, 95%; ¹⁵N, 95%; ¹³CH₃-ILVFY) | - |
| NEX-UB1-HIS-ILV-PK | His-ubiquitin (human) (¹³C, 95%; D, 95%; ¹⁵N, 95%; ¹³CH₃-ILV) | - |
| NEX-UB1-HIS-N-PK | His-ubiquitin (human) (¹⁵N, 95%) | - |
| NEX-UB1-HIS-U-PK | His-ubiquitin (human) (unlabeled) | - |
| NEX-UB1-ILVFY-PK | Ubiquitin (human) (¹³C, 95%; D, 95%; ¹⁵N, 95%; ¹³CH₃-ILVFY) | - |
| NEX-UB1-ILV-PK | Ubiquitin (human) (¹³C, 95%; D, 95%; ¹⁵N, 95%; ¹³CH₃-ILV) | - |
| NEX-UB1-N-PK | Ubiquitin (human) (¹⁵N, 95%) | - |
| NEX-UB1-N-P-PK | Ubiquitin (human) (¹⁵N, 95%) lyophilized powder | - |
| NEX-UB1-U-PK | Ubiquitin (human) (unlabeled) | - |
| NEX-XF1-CN-PK | X-Filtered NOESY NMR standard (¹³C, 95%; ¹⁵N, 95%) | - |
| NI5CCI-B | Coaxial inserts for NMR sample tubes 50mm capacity 100 UL | - |
| NILM-3663-PK | Nickel-62 metal (⁶²Ni) | - |
| NLM-1012-PK | Ethylamine·HCl (¹⁵N, 99%) | - |
| NLM-1016-0.1 | L-GLUTAMINE | 0.1G |
| NLM-1016-1 | L-GLUTAMINE | 1G |
| NLM-1016-MPT-PK | L-Glutamine (α-¹⁵N, 98%) microbiological/pyrogen tested | - |
| NLM-10295-1.2 | MICROCYSTIN-LR | 1.2ML |
| NLM-1031-0.1 | DL-LYSINE:2HCL | 0.1G |
| NLM-10340-1.2 | MICROCYSTIN-RR | 1.2ML |
| NLM-10343-1.2 | MICROCYSTIN-YR | 1.2ML |
| NLM-10345-1.2 | MICROCYSTIN-LA | 1.2ML |
| NLM-1042-1 | NITROBENZENE | 1G |
| NLM-1048-0.1MG | OROTIC ACID:H2O | 0.1MG |
| NLM-1048-0.25 | OROTIC ACID:H2O | 0.25G |
| NLM-1072-0.1 | SARCOSINE | 0.1G |
| NLM-108-0.5 | L-PHENYLALANINE | 0.5G |
| NLM-108-1 | L-PHENYLALANINE | 1G |
| NLM-108-MPT-PK | L-Phenylalanine (¹⁵N, 98%) microbiological/pyrogen tested | - |
| NLM-10907-MG-PK | Orotic acid, sodium salt (¹⁵N₂, 98%) | - |
| NLM-10907-PK | Orotic acid, sodium salt (¹⁵N₂, 98%) | - |
| NLM-11018-PK | D-Glucosamine·HCl (¹⁵N, 98%) | - |
| NLM-11609-SL-10 | Adenosine phosphoramidite (U-¹⁵N₅, 98%) CP 95% | - |
| NLM-11609-SL-50 | Adenosine phosphoramidite (U-¹⁵N₅, 98%) CP 95% | - |
| NLM-11610-SL-10 | Cytidine phosphoramidite (U-¹⁵N₃, 98%) CP 95% | - |
| NLM-11610-SL-50 | Cytidine phosphoramidite (U-¹⁵N₃, 98%) CP 95% | - |
| NLM-11611-SL-10 | Guanosine phosphoramidite (U-¹⁵N₅, 98%) CP 95% | - |
| NLM-11611-SL-50 | Guanosine phosphoramidite (U-¹⁵N₅, 98%) CP 95% | - |
| NLM-11612-SL-10 | Uridine phosphoramidite (U-¹⁵N₂, 98%) CP 95% | - |
| NLM-11612-SL-50 | Uridine phosphoramidite (U-¹⁵N₂, 98%) CP 95% | - |
| NLM-11619-PK | Cyclopropylamine (¹⁵N, 98%) | - |
| NLM-120-0.25 | L-ASPARAGINE:H2O | 0.25G |
| NLM-120-0.5 | L-ASPARAGINE:H2O | 0.5G |
| NLM-1208-0.25 | L-TRYPTOPHAN | 0.25G |
| NLM-1208-0.5 | L-TRYPTOPHAN | 0.5G |
| NLM-1265-1 | L-PHENYLALANINE-N-FMOC | 1G |
| NLM-1314-1 | ANILINE | 1G |
| NLM-1320-5 | AMMONIUM HYDROXIDE | 5GOFS |
| NLM-1328-0.25 | L-GLUTAMINE | 0.25G |
| NLM-135-0.5 | L-GLUTAMIC ACID | 0.5G |
| NLM-135-1 | L-GLUTAMIC ACID | 1G |
| NLM-142-0.5 | L-LEUCINE | 0.5G |
| NLM-142-1 | L-LEUCINE | 1G |
| NLM-142-MPT-PK | L-Leucine (¹⁵N, 98%) microbiological/pyrogen tested | - |
| NLM-143-0.25 | L-LYSINE:2HCL | 0.25G |
| NLM-143-1 | L-LYSINE:2HCL | 1G |
| NLM-143-MPT-PK | L-Lysine·2HCl (α-¹⁵N, 98%) microbiological/pyrogen tested | - |
| NLM-1513-0.25 | L-HISTIDINE:HCL:H2O | 0.25G |
| NLM-1513-MG-PK | L-Histidine·HCl·H₂O (¹⁵N₃, 98%) | - |
| NLM-1516-1 | FORMAMIDE | 1G |
| NLM-1554-0.1 | L-LYSINE:2HCL | 0.1G |
| NLM-157-1 | SODIUM NITRATE | 1G |
| NLM-157-5 | SODIUM NITRATE | 5G |
| NLM-1621-PK | Methylamine (¹⁵N, 98%) | - |
| NLM-1653-1 | DODECYLAMINE | 1G |
| NLM-1656-0.25 | BETA-ALANINE | 0.25G |
| NLM-1668-PK | DL-Cystine (¹⁵N₂, 95%) | - |
| NLM-1683-1 | DL-Lysine·HCl·H₂O (α-¹⁵N, 99%) | - |
| NLM-1695-0.1 | L-TRYPTOPHAN | 0.1G |
| NLM-1697-0.1 | URIC ACID | 0.1G |
| NLM-1697-0.5 | URIC ACID | 0.5G |
| NLM-1698-0.1 | XANTHINE | 0.1G |
| NLM-175-0.5 | ACETONITRILE | 0.5G |
| NLM-177-1 | AMMONIUM ACETATE | 1G |
| NLM-1903-0.25 | L-ALANINE-N-T-BOC | 0.25G |
| NLM-1903-0.5 | L-ALANINE-N-T-BOC | 0.5G |
| NLM-1903-1 | L-ALANINE-N-T-BOC | 1G |
| NLM-1904-1 | L-LEUCINE-N-T-BOC:H2O | 1G |
| NLM-1905-1 | L-Phenylalanine—Boc (¹⁵N, 98%) | - |
| NLM-1906-0.25 | L-TYROSINE-N-T-BOC, O-BZ ETHER | 0.25G |
| NLM-1908-0.25 | L-Aspartic acid—Boc, β-Bz ester (¹⁵N, 98%) | - |
| NLM-202-1 | GLYCINE | 1G |